NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Delayed Puberty


Return to Library

Free Delayed Puberty Articles


Researchers from St. Jude Children's Research Hospital describe findings in life sciences



2009 MAY 11 - (NewsRx.com) -- Research findings, 'Alterations in pubertal timing following therapy for childhood malignancies,' are discussed in a new report. "The onset of puberty marks a time of rapid linear growth, sexual development, and transition from childhood to maturity. The diagnosis and treatment of a childhood malignancy prior to the onset of puberty has the potential to profoundly affect the timing and the tempo of puberty," scientists in the United States report.

"CNS tumors located in the hypothalamic-pituitary (H-P) region, surgical resection in this location, and exposure to CNS radiotherapy are all associated with both precocious and delayed puberty. Also, chemotherapy and radiation can directly damage the gonads, which can result in absent, arrested, or delayed puberty. As a consequence of these alterations of pubertal timing, both male and female survivors of childhood cancer may be at risk of adult short-stature, decreased bone-mineral density, absent or incomplete sexual development, and ultimately, reduced rates of fertility," wrote G.T. Armstrong and colleagues, St. Jude Children's Research Hospital.

The researchers concluded: "Appropriate and timely assessment of survivors at high risk of alterations in pubertal development will enable the identification of patients who would benefit from early medical intervention."

Armstrong and colleagues published their study in Endocrine Development (Alterations in pubertal timing following therapy for childhood malignancies. Endocrine Development, 2009;15():25-39).

For more information, contact G.T. Armstrong, St. Jude Children's Research Hospital, Dept. of Epidemiology and Cancer Control, Memphis, Tenn USA..

Publisher contact information for the journal Endocrine Development is: Springer, 233 Spring Street, New York, NY 10013, USA.

Keywords: United States, Memphis, Life Sciences, Delayed Puberty, Drug Therapy, Chemotherapy, Treatment, Endocrine.

This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2009, Biotech Business Week via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login